Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 1
1977 1
1978 1
1979 1
1980 1
1981 1
1982 2
1983 1
1984 2
1985 1
1986 5
1987 1
1988 2
1989 3
1990 1
1991 4
1992 1
1993 2
1994 1
1995 2
1997 1
1999 4
2000 2
2001 2
2004 1
2005 2
2006 1
2007 1
2008 2
2009 6
2010 3
2011 2
2012 1
2013 1
2018 2
2019 1
2020 5
2021 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
A Series of Novel, Highly Potent, and Orally Bioavailable Next-Generation Tricyclic Peptide PCSK9 Inhibitors.
Tucker TJ, Embrey MW, Alleyne C, Amin RP, Bass A, Bhatt B, Bianchi E, Branca D, Bueters T, Buist N, Ha SN, Hafey M, He H, Higgins J, Johns DG, Kerekes AD, Koeplinger KA, Kuethe JT, Li N, Murphy B, Orth P, Salowe S, Shahripour A, Tracy R, Wang W, Wu C, Xiong Y, Zokian HJ, Wood HB, Walji A. Tucker TJ, et al. Among authors: branca d. J Med Chem. 2021 Nov 25;64(22):16770-16800. doi: 10.1021/acs.jmedchem.1c01599. Epub 2021 Oct 27. J Med Chem. 2021. PMID: 34704436
Orally Bioavailable Macrocyclic Peptide That Inhibits Binding of PCSK9 to the Low Density Lipoprotein Receptor.
Johns DG, Campeau LC, Banka P, Bautmans A, Bueters T, Bianchi E, Branca D, Bulger PG, Crevecoeur I, Ding FX, Garbaccio RM, Guetschow ED, Guo Y, Ha SN, Johnston JM, Josien H, Kauh EA, Koeplinger KA, Kuethe JT, Lai E, Lanning CL, Lee AYH, Li L, Nair AG, O'Neill EA, Stoch SA, Thaisrivongs DA, Tucker TJ, Vachal P, van Dyck K, Vanhoutte FP, Volckaert B, Wolford DG, Xu A, Zhao T, Zhou D, Zhou S, Zhu X, Zokian HJ, Walji AM, Wood HB. Johns DG, et al. Among authors: branca d. Circulation. 2023 Jul 11;148(2):144-158. doi: 10.1161/CIRCULATIONAHA.122.063372. Epub 2023 May 1. Circulation. 2023. PMID: 37125593 Free PMC article.
Calpain-related diseases.
Branca D. Branca D. Biochem Biophys Res Commun. 2004 Oct 1;322(4):1098-104. doi: 10.1016/j.bbrc.2004.07.126. Biochem Biophys Res Commun. 2004. PMID: 15336956 Review.
Generation, control, and processing of cellular calcium signals.
Carafoli E, Santella L, Branca D, Brini M. Carafoli E, et al. Among authors: branca d. Crit Rev Biochem Mol Biol. 2001 Apr;36(2):107-260. doi: 10.1080/20014091074183. Crit Rev Biochem Mol Biol. 2001. PMID: 11370791 Review.
Testing rimegepant for migraine-time to revise the trial design?
Gasparini S, Torino C, Branca D, Ferlazzo E, Aguglia U. Gasparini S, et al. Among authors: branca d. Lancet. 2020 Jun 20;395(10241):1901. doi: 10.1016/S0140-6736(20)30241-5. Lancet. 2020. PMID: 32563366 No abstract available.
N-(2-alkylaminoethyl)-4-(1,2,4-oxadiazol-5-yl)piperazine-1-carboxamides as highly potent smoothened antagonists.
Muraglia E, Ontoria JM, Branca D, Dessole G, Bresciani A, Fonsi M, Giuliano C, Llauger Bufi L, Monteagudo E, Palumbi MC, Torrisi C, Rowley M, Steinkühler C, Jones P. Muraglia E, et al. Among authors: branca d. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5283-8. doi: 10.1016/j.bmcl.2011.07.030. Epub 2011 Jul 14. Bioorg Med Chem Lett. 2011. PMID: 21802943
72 results